申请人:Taiho Pharmaceutical Co., Ltd.
公开号:EP3345907A1
公开(公告)日:2018-07-11
To provide a novel compound having a HER2 inhibitory effect and having a cytostatic effect. It is also intended to provide a medicament useful in the prevention and/or treatment of a disease involving HER2, particularly, cancer, on the basis of the HER2 inhibitory effect.
The present invention provides a compound of formula (I) wherein X, Y, Z1, Z2, Z3, Z4, W, n, R1, R2, and R3 have meanings as defined in the present specification, or a salt thereof.
提供一种具有 HER2 抑制作用和细胞抑制作用的新型化合物。本发明还旨在提供一种基于 HER2 抑制作用、可用于预防和/或治疗涉及 HER2 的疾病(尤其是癌症)的药物。
本发明提供了式(I)化合物,其中X、Y、Z1、Z2、Z3、Z4、W、n、R1、R2和R3具有本说明书中定义的含义,或其盐。